Fig.2 Research findings on endovascular implantation of metallic molybdenum (a, b) EDS analyses confirmed biodegradation product film formation[73] (d—diameter) (c) immunofluorescence staining showed endothelial (CD31) and smooth muscle actin (α-SMA) responses around Mo and Pt implants[73] (d, e) radiograph, µCT, and explant views revealed implant retention and vascular integration up to 12 months[74] (f, g) hematoxylin and eosin (H&E) (f) and Masson staining (g) confirmed vascular tissue responses in rat abdominal aortae[16] (AM—additive manufacturing) (h) SEM image (BSE mode) at 3 months demonstrated stent strut degradation with visible products[16] (i) degradation products were characterized by SEM-EDS, TEM, EDS mapping, and SAED pattern of focused ion beam (FIB)-sampled regions[16] (j) application of Mo wire braided stents and coils in treating intracranial ischemic and hemorrhagic strokes and schematic workflow for evaluating the histopathological and functional safety of Mo neuro-implant[75] (tMCAO—transient middle cerebral artery occlusion) (k) in vivo neurological function effect of Mo braided stent wire[75] (MCAO—middle cerebral artery occlusion model) (l) in vivo biosafety of 2D Mo coil[75]
|